Abstract:Implanted biomaterials play a key role in current success of orthopedic and trauma surgery. However, implant-related infections remain among the leading reasons for failure with high economical and social associated costs. According to the current knowledge, probably the most critical pathogenic event in the development of implant-related infection is biofilm formation, which starts immediately after bacterial adhesion on an implant and effectively protects the microorganisms from the immune system and systemic antibiotics. A rationale, modern prevention of biomaterial-associated infections should then specifically focus on inhibition of both bacterial adhesion and biofilm formation. Nonetheless, currently available prophylactic measures, although partially effective in reducing surgical site infections, are not based on the pathogenesis of biofilm-related infections and unacceptable high rates of septic complications, especially in high-risk patients and procedures, are still reported.In the last decade, several studies have investigated the ability of implant surface modifications to minimize bacterial adhesion, inhibit biofilm formation, and provide effective bacterial killing to protect implanted biomaterials, even if there still is a great discrepancy between proposed and clinically implemented strategies and a lack of a common language to evaluate them.To move a step forward towards a more systematic approach in this promising but complicated field, here we provide a detailed overview and an original classification of the various technologies under study or already in the market. We may distinguish the following: 1. Passive surface finishing/modification (PSM): passive coatings that do not release bactericidal agents to the surrounding tissues, but are aimed at preventing or reducing bacterial adhesion through surface chemistry and/or structure modifications; 2. Active surface finishing/modification (ASM): active coatings that feature pharmacologically active pre-incorporated bactericidal agents; and 3. Local carriers or coatings (LCC): local antibacterial carriers or coatings, biodegradable or not, applied at the time of the surgical procedure, immediately prior or at the same time of the implant and around it. Classifying different technologies may be useful in order to better compare different solutions, to improve the design of validation tests and, hopefully, to improve and speed up the regulatory process in this rapidly evolving field.

Implants coating strategies for antibacterial treatment in fracture and defect models: A systematic review of animal studies

Research Progress on Antibacterial Coatings for Preventing Implant-Related Infection in Fractures: A Literature Review

Antibacterial coatings on orthopedic implants

Antibacterial and Anti-Inflammatory Coating Materials for Orthopedic Implants: A Review

Surface coating of orthopedic implant to enhance the osseointegration and reduction of bacterial colonization: a review

Antibiotic cement coating in orthopedic surgery: a systematic review of reported clinical techniques

Current therapeutic interventions combating biofilm-related infections in orthopaedics : a systematic review of in vivo animal studies

A Review on Antimicrobial Coatings for Biomaterial Implants and Medical Devices.

An Improved 2-Aminoimidazole Based Anti-Biofilm Coating for Orthopedic Implants: Activity, Stability, and in vivo Biocompatibility

Emerging Strategies to Prevent Bacterial Infections on Titanium‐Based Implants

A systematic review on current osteosynthesis-associated infection animal fracture models

Recent Progress in antibacterial hydrogel coatings for targeting biofilm to prevent orthopedic implant-associated infections

Antimicrobial coating strategy to prevent orthopaedic device-related infections: recent advances and future perspectives

Bacteria biomembrane formation and anti-bacterial surface modification of implants

Current Progress and Future Perspectives in Contact and Releasing-Type Antimicrobial Coatings of Orthopaedic Implants: A Systematic Review Analysis Emanated from In Vitro and In Vivo Models

Antibacterial coating of implants in orthopaedics and trauma: a classification proposal in an evolving panorama

Remote Eradication of Bacteria on Orthopedic Implants Via Delayed Delivery of Polycaprolactone Stabilized Polyvinylpyrrolidone Iodine

Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus aureus Infection in an Open Fracture Animal Model

Antibacterial Immunonegative Coating with Biocompatible Materials on a Nanostructured Titanium Plate for Orthopedic Bone Fracture Surgery

Recent Advances in Antibacterial Coatings to Combat Orthopedic Implant-Associated Infections

Current therapeutic interventions combating biofilm-related infections in orthopaedics